CBT:NYE-Cabot Corporation (USD)

COMMON STOCK | Specialty Chemicals | NYE

Last Closing Price

USD 55.63

Change

0.00 (0.00)%

Market Cap

USD 3.16B

Volume

0.31M

Avg Analyst Target

USD 70.83 (+27.33%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


Cabot Corporation (CBT) Stock Analysis:
Based on the Cabot Corporation stock forecasts from 5 analysts, the average analyst target price for Cabot Corporation is USD 70.83 over the next 12 months. Cabot Corporation’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Cabot Corporation is Slightly Bullish , which is based on 8 positive signals and 4 negative signals. At the last closing, Cabot Corporation’s stock price was USD 55.63. Cabot Corporation’s stock price has changed by -5.43% over the past week, +1.05% over the past month and +18.11% over the last year.

About

Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through three segments: Reinforcement Materials, Performance Chemicals, and Purification Solutions. The company offers reinforcing carbons used in tires as a rubber reinforcing agen ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-01-23 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
LIN Linde plc

N/A

USD164.88B 54.16 18.89
SHW The Sherwin-Williams Company

N/A

USD76.78B 40.12 26.38
APD Air Products and Chemicals Inc

N/A

USD62.62B 29.94 17.08
ECL Ecolab Inc

N/A

USD55.91B 49.88 28.62
DD DuPont de Nemours Inc

N/A

USD40.14B 7.16 11.62
PPG PPG Industries Inc

N/A

USD36.74B 25.75 17.81
IFF International Flavors & Fragra..

N/A

USD35.46B 119.36 32.50
LYB LyondellBasell Industries N.V

N/A

USD31.45B 5.52 4.94
ALB Albemarle Corporation

N/A

USD24.89B 114.01 62.73
AVTR Avantor Inc

N/A

USD21.99B 45.61 22.51

ETFs Containing CBT

Symbol Name Weight Mer Price(Change) Market Cap
DES WisdomTree U.S. SmallCap .. 0.00 % 0.38 %

N/A

USD1.92B
FHM:CA First Trust NYSE Arca Bio.. 0.00 % 0.80 %

N/A

USD0.91M

Market Performance

  Market Performance vs.
Industry/Classification (Specialty Chemicals)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.01% 76% C 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.01% 76% C 67% D+
Trailing 12 Months  
Capital Gain 18.11% 70% C- 77% C+
Dividend Return 3.01% 79% C+ 51% F
Total Return 21.13% 74% C 77% C+
Trailing 5 Years  
Capital Gain -0.39% 31% F 34% F
Dividend Return 12.09% 58% F 47% F
Total Return 11.69% 34% F 29% F
Average Annual (5 Year Horizon)  
Capital Gain 3.57% 28% F 41% F
Dividend Return 2.88% 80% B- 64% D
Total Return 6.44% 33% F 40% F
Risk Return Profile  
Volatility (Standard Deviation) 33.69% 51% F 33% F
Risk Adjusted Return 19.12% 30% F 24% F
Market Capitalization 3.16B 47% F 67% D+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Specialty Chemicals)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 12.82 74% C 65% D
Price/Book Ratio 3.37 45% F 30% F
Price / Cash Flow Ratio 12.30 57% F 39% F
EV/EBITDA 6.94 83% B 74% C
Management Effectiveness  
Return on Equity 30.04% 80% B- 84% B
Return on Invested Capital 16.91% 91% A- 88% B+
Return on Assets 9.47% 91% A- 90% A-
Debt to Equity Ratio 75.71% 51% F 47% F
Technical Ratios  
Short Ratio 3.86 30% F 22% F
Short Percent 1.94% 44% F 61% D-
Beta 1.64 26% F 18% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Underpriced on free cash flow basis

The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.